Rating Change
Guggenheim analysts initiated coverage on Eloxx Pharmaceuticals, Inc. (OTC:ELOX) with a Buy rating on July 20, 2026.
new coverageOTC:ELOX
Guggenheim Initiates Coverage on Eloxx Pharmaceuticals, Inc. (ELOX) with Buy
Rating Change Guggenheim analysts initiated coverage on Eloxx Pharmaceuticals, Inc. (OTC:ELOX) with a Buy rating on July 20, 2026. Market Context Eloxx Pharmaceuticals, Inc.
Market Context
Eloxx Pharmaceuticals, Inc. operates in the Healthcare sector. The stock currently trades at $12.20 with a market capitalization of 314.0.
Analyst coverage from Guggenheim provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Eloxx Pharmaceuticals, Inc..
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Recent Analyst Activity for Eloxx Pharmaceuticals, Inc.
Among the 10 most recent ratings: 7 Buy, 3 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Jul 20, 2026 | Guggenheim | Buy | N/A |
| Jul 11, 2023 | Oppenheimer | Outperform | N/A |
| Apr 06, 2023 | Oppenheimer | Outperform | N/A |
| May 23, 2022 | Piper Sandler | Overweight | N/A |
| May 09, 2022 | HC Wainwright & Co. | Neutral | N/A |
Related Tools: Analyst Ratings Dashboard | View ELOX Stock Page
Frequently Asked Questions
What does a Buy rating mean for ELOX?
A Buy rating from Guggenheim reflects the analyst's outlook on Eloxx Pharmaceuticals, Inc. (OTC:ELOX). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Where can I find more analyst ratings?
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the ELOX forecast page.
